Jeffrey W. Jacobs, Chief Scientific Officer at ARDELYX, INC. (ARDX), sold 5,754 shares at $0.98 ($6K) on 2021-11-22, disclosed to the SEC on 2021-11-24.
Scheduled sale ($6k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.98 | 5,000 | $5K | 86.8% |
| 2 | $0.99 | 754 | $746 | 13.2% |
| Total | $0.98 avg | 5,754 | $6K | 100% |
| Filing → |
| ARDX | SELL | 2021-08-24 | $978 | — | Filing → |
| ARDX | SELL | 2021-06-17 | $55K | — | Filing → |
| ARDX | SELL | 2021-05-21 | $5K | — | Filing → |